{"id":21077,"date":"2025-08-24T23:26:08","date_gmt":"2025-08-24T23:26:08","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/21077\/"},"modified":"2025-08-24T23:26:08","modified_gmt":"2025-08-24T23:26:08","slug":"hcplive-5-stories-in-under-5-week-of-08-17","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/21077\/","title":{"rendered":"HCPLive 5 Stories in Under 5: Week of 08\/17"},"content":{"rendered":"

Welcome to HCPLive’s 5 Stories in Under 5\u2014your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let\u2019s dive into the latest updates impacting clinicians and healthcare providers like you!<\/p>\n

Interested in a more traditional, text rundown? Check out the HCPFive<\/a>!<\/p>\n

Top 5 Healthcare Headlines for August 17-23, 2025:<\/strong>
1. FDA Approves Donidalorsen to Prevent Hereditary Angioedema Attacks<\/strong><\/a><\/p>\n

The FDA approved donidalorsen (DAWNZERA) for preventing HAE attacks in patients 12 years and older, supported by phase 3 OASIS trial data.<\/p>\n

2. FDA Grants Atumelnant Orphan Drug Designation for Congenital Adrenal Hyperplasia<\/strong><\/a><\/p>\n

Atumelnant received FDA Orphan Drug Designation after phase 2 results showed rapid, sustained reductions in key biomarkers for congenital adrenal hyperplasia.<\/p>\n

3. Semaglutide Reduces Medical Costs, Healthcare Resource Utilization in Heart Failure<\/strong><\/a><\/p>\n

A real-world analysis found semaglutide 2.4 mg reduced all-cause medical costs by 28% and inpatient hospitalization costs by 55% in patients with obesity and heart failure.<\/p>\n

4. RE104 Reduces Postpartum Depression Symptoms by Day 7 in Phase 2 RECONNECT<\/strong><\/a><\/p>\n

RE104 significantly reduced depressive symptoms by day 7 in patients with postpartum depression, meeting the phase 2 RECONNECT trial\u2019s primary endpoint.<\/p>\n

5. Dyslipidemia, Other Metabolic Syndrome Factors May Raise Parkinson\u2019s Disease Risk<\/strong><\/a><\/p>\n

People with metabolic syndrome had about a 40% higher risk of developing Parkinson\u2019s disease compared with those without the condition.<\/p>\n","protected":false},"excerpt":{"rendered":"Welcome to HCPLive’s 5 Stories in Under 5\u2014your quick, must-know recap of the top 5 healthcare stories from…\n","protected":false},"author":2,"featured_media":21078,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[78],"tags":[2904,2908,2901,2906,2675,686,718,18,2909,2898,1910,135,474,2911,19,2913,2902,1911,2810,17,693,96,5,2907,2900,2899,1944,2903,171,2905,2912,172,2910,133,2897],"class_list":{"0":"post-21077","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health","8":"tag-allergy","9":"tag-cardiology","10":"tag-clinicians","11":"tag-dermatology","12":"tag-diabetes","13":"tag-doctors","14":"tag-drugs","15":"tag-eire","16":"tag-endocrinology","17":"tag-fda","18":"tag-gastroenterology","19":"tag-health","20":"tag-healthcare","21":"tag-hematology","22":"tag-ie","23":"tag-infectious-disease","24":"tag-insight","25":"tag-internal-medicine","26":"tag-interviews","27":"tag-ireland","28":"tag-medical","29":"tag-medicine","30":"tag-news","31":"tag-ophthalmology","32":"tag-pharmaceuticals","33":"tag-pipeline","34":"tag-primary-care","35":"tag-providers","36":"tag-psychiatry","37":"tag-pulmonology","38":"tag-rare-disease","39":"tag-research","40":"tag-rheumatology","41":"tag-science","42":"tag-treatments"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/21077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=21077"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/21077\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/21078"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=21077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=21077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=21077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}